本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Regenxbio Inc

14.97
+0.38002.60%
盤後14.970.00000.00%16:10 EST
成交量:59.80萬
成交額:901.18萬
市值:7.58億
市盈率:-4.32
高:15.41
開:14.74
低:14.61
收:14.59
52周最高:15.41
52周最低:5.04
股本:5,062.31萬
流通股本:4,142.31萬
量比:0.69
換手率:1.44%
股息:- -
股息率:- -
每股收益(TTM):-3.4644
每股收益(LYR):-4.5871
淨資產收益率:-76.88%
總資產收益率:-18.54%
市淨率:4.69
市盈率(LYR):-3.26

資料載入中...

2024/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/26

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/25

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/18

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/09/01

重要事件披露

Form 8-K - Current report
2023/08/02

重要事件披露

Form 8-K - Current report
2023/08/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/06

重要事件披露

Form 8-K - Current report
2023/05/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/05/03

重要事件披露

8-K - Current report